Author: <span>Walter Pacheco</span>

New Zealand Asbestos Guide Aims to Reduce Deaths

New Zealand has a new guide for managing and removing asbestos in the workplace. The “Approved Code of Practice for the Management and Removal of Asbestos,” or ACOP, was designed to complement the Health and Safety at Work (Asbestos) Regulations 2016. Described as the first for the country, the new guide hopes to cut asbestos-related…

The post New Zealand Asbestos Guide Aims to Reduce Deaths appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Mining Town in Canada Searches for New Identity

Asbestos wasn’t always an ugly word. Once hailed as a miracle fiber in manufacturing and construction, it is now scorned for its toxicity and link to mesothelioma and other deadly respiratory diseases. Perhaps no place knows that fall from grace better than the small town of Asbestos in southeast Quebec. Not only did the asbestos…

The post Asbestos Mining Town in Canada Searches for New Identity appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Red Wine Chemical Enhances Mesothelioma Chemotherapy

A new experimental treatment combining a chemical found in red wine and a popular chemotherapy drug showed a powerful synergistic effect in targeting pleural mesothelioma cells. Researchers at Soon Chun Hyang University Hospital Cheonan in South Korea combined the platinum-based chemotherapy drug cisplatin with resveratrol, a natural antioxidant found in wine and red grapes. The…

The post Red Wine Chemical Enhances Mesothelioma Chemotherapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Using Keytruda for Mesothelioma May Become a Reality

The U.S. Food and Drug Administration recently upgraded its approval of pembrolizumab (Keytruda) for metastatic non-small cell lung cancer, inching it closer to becoming an accepted treatment option for pleural mesothelioma. Pembrolizumab, produced by pharmaceutical giant Merck & Co., also is marketed as Keytruda. The FDA’s announcement last week converted its previous “accelerated” approval in…

The post Using Keytruda for Mesothelioma May Become a Reality appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Definitive Radiation Therapy Extends Mesothelioma Survival

Patients with pleural mesothelioma are missing a chance to increase survival time because they are underutilizing definitive radiation, according to a recent study by the Icahn School of Medicine at Mount Sinai in New York City. A team of doctors found that overall survival at the two- and five-year marks almost doubled for the small…

The post Definitive Radiation Therapy Extends Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Hoboken Train Crash Stirs Asbestos Concerns

High asbestos levels and extensive debris delayed the federal investigation of the Hoboken train crash in New Jersey for more than a week, officials said. Although officials reopened the majority of the rails at the Hoboken terminal this week, efforts to completely clean the century-old terminal will take even longer. The Sept. 29 crash killed…

The post Hoboken Train Crash Stirs Asbestos Concerns appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Researchers Treat Mesothelioma with Precision Medicine

Targeted therapy aimed at specific genetic mutations can lead to significant improvement in progression-free survival for many cancer patients, including those with mesothelioma, a recent study shows. The research team at Intermountain Precision Genomics in St. George, Utah, found that matching tumor-related genetic mutations to drugs specific to the corresponding abnormality slows or stops many…

The post Researchers Treat Mesothelioma with Precision Medicine appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Peritoneal Mesothelioma Grading System Improves Prognosis

The first two-tier grading system for peritoneal mesothelioma has produced a significant subset of patients with an incredible median overall survival of nearly 12 years. That pathology-based grading system should provide patients with a more accurate prognosis, potentially helping doctors design more personalized and effective therapies. “We can tell patients now what the future holds….

The post Peritoneal Mesothelioma Grading System Improves Prognosis appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’

Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations,…

The post Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’

Thoracic surgeon and mesothelioma visionary Dr. David Sugarbaker already is thinking two steps ahead, anticipating the optimal utilization of this latest clinical trial drug combination. That’s what leaders do. A phase II, multicenter clinical trial involving the antibody-drug conjugate anetumab ravtansine (BAY 94-9343) for patients with stage IV pleural mesothelioma opened recently with considerable expectations,…

The post Sugarbaker: Mesothelioma Clinical Trial May Be ‘Home Run’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

FDA Speeds Possible Second-Line Treatment for Mesothelioma

The U.S. Food and Drug Administration awarded Fast Track designation recently to the WT1 cancer vaccine, moving it closer to becoming the first approved second-line treatment for malignant pleural mesothelioma. The vaccine, also known as galinpepimut-S, is an immunotherapy agent that targets the WT1 protein, which is expressed in high levels in various cancers, such…

The post FDA Speeds Possible Second-Line Treatment for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study: Onconase, Malaria Drug Extends Mesothelioma Survival

A new treatment combining two existing drugs — one derived from frog eggs and another given to combat malaria — may be the key to extending mesothelioma survival. Scientists at Tongji University in Shanghai, China, discovered that mixing Onconase, an enzyme present in early-stage leopard frog embryos, with antimalarial drug dihydroartemisinin (DHA) synergistically suppressed growth…

The post Study: Onconase, Malaria Drug Extends Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New Lung Cancer Study May Improve Mesothelioma Therapy

New insight into the gene responsible for the most aggressive subtype of non-small cell lung cancer (NSCLC) could bring hope for mesothelioma patients. Researchers from UT Southwestern Medical Center identified a new way to target lung cancer through the Kirsten rat sarcoma viral oncogene homolog, also known as the KRAS gene. Tumors that carry a…

The post New Lung Cancer Study May Improve Mesothelioma Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Orlando Won’t Face Fines for Exposing Firefighters to Asbestos

City of Orlando and Orlando Fire Department officials will not face any fines after firefighters were exposed to asbestos during a training exercise in February. Investigators met with Orange County Environmental Protection Division (EPD) officials and decided not to impose any penalties, which could have amounted to $25,000 for each violation. Instead, fire department officials…

The post Orlando Won’t Face Fines for Exposing Firefighters to Asbestos appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Sen. Boxer: EPA Should Include Asbestos in Top Priorities

Selecting the 10 most dangerous chemicals in the U.S. is the first order of business under the recently strengthened arm of the Environmental Protection Agency. “EPA must consider all forms of asbestos in this initial list of chemicals it acts on,” U.S. Sen. Barbara Boxer, D-Calif., wrote in an Aug. 26 letter to EPA administrator…

The post Sen. Boxer: EPA Should Include Asbestos in Top Priorities appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.